Skip to Content

Stéphane Bancel

Stéphane Bancel is the CEO of the biotech company Moderna, made famous by its pioneering mRNA technology that allowed it to develop a COVID-19 vaccine in record time. Before joining Moderna in 2011, Stéphane was the CEO of the French diagnostics company bioMérieux SA for five years. Prior to that, he served in various roles at pharmaceutical firm Eli Lilly and Company. He serves on the board of directors of Indigo and is a Venture Partner at Flagship Pioneering.

“This is a team sport, and there are a lot of amazing people that have been part of making this vaccine possible.”

— Stéphane Bancel
Featured in these episodes:
Stéphane Bancel, guest
May 31, 2022

A diverse network of collaborators is key when making scale leaps. Moderna CEO Stéphane Bancel has cultivated a wide network of scientists, business leaders, and government officials across his career. When COVID-19 struck, Bancel called upon this nexus of experts to aid the warp-speed development of the mRNA-based vaccine in the race to save millions of lives.

Stéphane Bancel, guest
May 24, 2022

If you’re launching a moonshot, success depends on how you manage the trajectory of risk. When Stéphane Bancel became Moderna’s first CEO, the biotech start-up was chasing a way-out idea many experts thought was impossible. Stéphane built a culture of calculated risk-taking to create a platform for extraordinary leaps — one that enabled life-saving mRNA vaccines when Covid-19 struck.

Stéphane Bancel, cameo
October 4, 2022

Taking risks can be the catalyst for immense scale or dire straits. Avoiding taking any risks at all leads to stagnancy and empowered competitors. The key is to know which risks are worth taking, and when and how to take them. This episode highlights the best conversations we’ve had recently about taking advantage of risk and how fortune favors the brave.